Hangzhou Coco Healthcare ProductsLtd Future Growth
Future criteria checks 3/6
Hangzhou Coco Healthcare ProductsLtd is forecast to grow earnings and revenue by 29.5% and 12% per annum respectively. EPS is expected to grow by 30.8% per annum. Return on equity is forecast to be 3.7% in 3 years.
Key information
29.5%
Earnings growth rate
30.8%
EPS growth rate
Household Products earnings growth | 27.2% |
Revenue growth rate | 12.0% |
Future return on equity | 3.7% |
Analyst coverage | Low |
Last updated | 16 May 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,477 | 69 | N/A | -149 | 1 |
12/31/2025 | 1,346 | 56 | N/A | 313 | 1 |
12/31/2024 | 1,214 | 45 | N/A | -45 | 1 |
3/31/2024 | 1,046 | 27 | 147 | 221 | N/A |
12/31/2023 | 1,081 | 20 | 162 | 228 | N/A |
9/30/2023 | 1,144 | -31 | 67 | 138 | N/A |
6/30/2023 | 1,173 | -22 | -23 | 66 | N/A |
3/31/2023 | 1,183 | -34 | -68 | 10 | N/A |
1/1/2023 | 1,186 | -43 | -154 | -37 | N/A |
9/30/2022 | 1,169 | -15 | -78 | 48 | N/A |
6/30/2022 | 1,132 | -27 | -123 | 29 | N/A |
3/31/2022 | 1,175 | 1 | -153 | 72 | N/A |
1/1/2022 | 1,186 | 40 | -190 | 51 | N/A |
9/30/2021 | 1,269 | 115 | -110 | 145 | N/A |
6/30/2021 | 1,466 | 150 | -6 | 236 | N/A |
3/31/2021 | 1,654 | 207 | N/A | N/A | N/A |
12/31/2020 | 1,635 | 214 | 175 | 396 | N/A |
12/31/2019 | 1,174 | 87 | 97 | 223 | N/A |
12/31/2018 | 906 | 60 | 24 | 114 | N/A |
12/31/2017 | 787 | 42 | N/A | 110 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301009's forecast earnings growth (29.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 301009's earnings (29.5% per year) are forecast to grow faster than the CN market (22.1% per year).
High Growth Earnings: 301009's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301009's revenue (12% per year) is forecast to grow slower than the CN market (13.6% per year).
High Growth Revenue: 301009's revenue (12% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301009's Return on Equity is forecast to be low in 3 years time (3.7%).